Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 321

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study

Open access
Reyes, Jinnethe, Komarow, Lauren, Chen, Liang, Ge, Lizhao, Hanson, Blake M, Cober, Eric, Herc, Erica, Alenazi, Thamer, Kaye, Keith S, Garcia-Diaz, Julia, Li, Lanjuan, Kanj, Souha S, Liu, Zhengyin, Oñate, Jose M, Salata, Robert A, Marimuthu, Kalisvar, Gao, Hainv, Zong, Zhiyong, Valderrama-Beltrán, Sandra L, Yu, Yunsong, Tambyah, Paul, Weston, Gregory, Salcedo, Soraya, Abbo, Lillian M, Xie, Qing, Ordoñez, Karen, Wang, Minggui, Stryjewski, Martin E, Munita, Jose M, Paterson, David L, Evans, Scott, Hill, Carol, Baum, Keri, Bonomo, Robert A, Kreiswirth, Barry N, Villegas, Maria Virginia, Patel, Robin, Arias, Cesar A, Chambers, Henry F, Fowler, Vance G, Doi, Yohei, van Duin, David, Satlin, Michael J, Reyes, Jinnethe, Komarow, Lauren, Chen, Liang, Ge, Lizhao, Hanson, Blake, Cober, Eric, Herc, Erica, Alenazi, Thamer, Kaye, Keith, Garcia-Diaz, Julia, Li, Lanjuan, Kanj, Souha, Liu, Zhengyin, Oñate, Jose, Salata, Robert, Marimuthu, Kalisvar, Gao, Hainv, Zong, Zhiyong, Valderrama-Beltrán, Sandra, Yu, Yunsong, Tambyah, Paul, Weston, Gregory, Salcedo, Soraya, Abbo, Lillian, Xie, Qing, Ordoñez, Karen, Wang, Minggui, Stryjewski, Martin, Munita, Jose, Paterson, David, Evans, Scott, Hill, Carol, Baum, Keri, Bonomo, Robert, Kreiswirth, Barry, Virginia Villegas, Maria, Patel, Robin, Arias, Cesar, Chambers, Henry, Fowler, Vance, Doi, Yohei, van Duin, David, Satlin, Michael · 2023 · The Lancet Microbe

Abstract

BACKGROUND: Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a global threat, but the distribution and clinical significance of carbapenemases are unclear. The aim of this study was to define characteristics and outcomes of CRPA infections and the global frequency and clinical impact of carbapenemases harboured by CRPA. METHODS: We conducted an observational, prospective cohort study of CRPA isolated from bloodstream, respiratory, urine, or wound cultures of patients at 44 hospitals (10 countries) between Dec 1, 2018, and Nov 30, 2019. Clinical data were abstracted from health records and CRPA isolates were whole-genome sequenced. The primary outcome was 30-day mortality from the day the index culture was collected. We compared outcomes of patients with CRPA infections by infection type and across geographic regions and performed an inverse probability weighted analysis to assess the association between carbapenemase production and 30-day mortality. FINDINGS: We enrolled 972 patients (USA n=527, China n=171, south and central America n=127, Middle East n=91, Australia and Singapore n=56), of whom 581 (60%) had CRPA infections. 30-day mortality differed by infection type (bloodstream 21 [30%] of 69, respiratory 69 [19%] of 358, wound nine [14%] of 66, urine six [7%] of 88; p=0·0012) and geographical region (Middle East 15 [29%] of 52, south and central America 20 [27%] of 73, USA 60 [19%] of 308, Australia and Singapore three [11%] of 28, China seven [6%] of 120; p=0·0002). Prevalence of carbapenemase genes among CRPA isolates also varied by region (south and central America 88 [69%] of 127, Australia and Singapore 32 [57%] of 56, China 54 [32%] of 171, Middle East 27 [30%] of 91, USA ten [2%] of 527; p<0·0001). KPC-2 (n=103 [49%]) and VIM-2 (n=75 [36%]) were the most common carbapenemases in 211 carbapenemase-producing isolates. After excluding USA patients, because few US isolates had carbapenemases, patients with carbapenemase-producing CRPA infections had higher 30-day mortality than those with non-carbapenemase-producing CRPA infections in both unadjusted (26 [22%] of 120 vs 19 [12%] of 153; difference 9%, 95% CI 3-16) and adjusted (difference 7%, 95% CI 1-14) analyses. INTERPRETATION: The emergence of different carbapenemases among CRPA isolates in different geographical regions and the increased mortality associated with carbapenemase-producing CRPA infections highlight the therapeutic challenges posed by these organisms. FUNDING: National Institutes of Health.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2666-5247(22)00329-9

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 321

Metadata

Authors
Reyes, J., Komarow, L., Chen, L., Ge, L., Hanson, B. M., Cober, E., Herc, E., Alenazi, T., Kaye, K. S., Garcia-Diaz, J., Li, L., Kanj, S. S., Liu, Z., Oñate, J. M., Salata, R. A., Marimuthu, K., Gao, H., Zong, Z., Valderrama-Beltrán, S. L., Yu, Y., Tambyah, P., Weston, G., Salcedo, S., Abbo, L. M., Xie, Q., Ordoñez, K., Wang, M., Stryjewski, M. E., Munita, J. M., Paterson, D. L., Evans, S., Hill, C., Baum, K., Bonomo, R. A., Kreiswirth, B. N., Villegas, M. V., Patel, R., Arias, C. A., Chambers, H. F., Fowler, V. G., Doi, Y., van Duin, D., Satlin, M. J., Reyes, J., Komarow, L., Chen, L., Ge, L., Hanson, B., Cober, E., Herc, E., Alenazi, T., Kaye, K., Garcia-Diaz, J., Li, L., Kanj, S., Liu, Z., Oñate, J., Salata, R., Marimuthu, K., Gao, H., Zong, Z., Valderrama-Beltrán, S., Yu, Y., Tambyah, P., Weston, G., Salcedo, S., Abbo, L., Xie, Q., Ordoñez, K., Wang, M., Stryjewski, M., Munita, J., Paterson, D., Evans, S., Hill, C., Baum, K., Bonomo, R., Kreiswirth, B., Virginia Villegas, M., Patel, R., Arias, C., Chambers, H., Fowler, V., Doi, Y., van Duin, D., & Satlin, M.
Venue
The Lancet Microbe
Publisher
Elsevier BV
Published
2023-03
Volume
4
Issue
3
Pages
e159-e170
ISSN
2666-5247 (ISSN-L)
OpenAlex
W4319661295
Cited by
321
References
25
FWCI
22.41
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study. https://app.cochat.ai/papers/10.1016/s2666-5247(22)00329-9
The paper
Reyes, J., Komarow, L., Chen, L., Ge, L., Hanson, B. M., Cober, E., Herc, E., Alenazi, T., Kaye, K. S., Garcia-Diaz, J., Li, L., Kanj, S. S., Liu, Z., Oñate, J. M., Salata, R. A., Marimuthu, K., Gao, H., Zong, Z., Valderrama-Beltrán, S. L., . . . Satlin, M. (2023). Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study. The Lancet Microbe. https://doi.org/10.1016/s2666-5247(22)00329-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.